Contemporary Incidence and Predictors of Stent Thrombosis and Other Major Adverse Cardiac Events in the Year After XIENCE V Implantation-Reference-Cited by-同舟云学术

Contemporary Incidence and Predictors of Stent Thrombosis and Other Major Adverse Cardiac Events in the Year After XIENCE V Implantation

Published:2012-06 Issue:6 Volume:5 Page:626-635
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

Naidu Srihari S.,Krucoff Mitchell W.,Rutledge David R.,Mao Vivian W.,Zhao Weiying,Zheng Qing,Wilburn Olivia,Sudhir Krishnankutty,Simonton Charles,Hermiller James B.

Funder

Abbott Vascular

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference28 articles.

1. Off-label use of drug-coated stents: putting it in perspective;Grines;J Am Coll Cardiol,2008

2. Late thrombosis in drug-coated coronary stents after discontinuation of antiplatelet therapy;McFadden;Lancet,2004

3. Late angiographic stent thrombosis (LAST) events with drug-coated stents;Ong;J Am Coll Cardiol,2005

4. Outcomes associated with drug-coated and bare metal stents: a collaborative network meta-analysis;Stettler;Lancet,2007

5. Safety and efficacy of sirolimus- and paclitaxel-coated coronary stents;Stone;N Engl J Med,2007

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Second-generation everolimus-eluting intracoronary stents: a comprehensive review of the clinical evidence;Future Cardiology;2024-01-31

2. Clinically Driven Revascularization in High-Risk Patients Treated With Ticagrelor Monotherapy After PCI: Insights from the Randomized TWILIGHT Trial;The American Journal of Cardiology;2023-12

3. Impact of post-implantation time on bioresorbable vascular scaffold outcomes for type C versus non-type C coronary lesions: A longer-term study;Journal of the Formosan Medical Association;2023-10

4. Biolimus-eluting vs. other limus-eluting stents in NSTE-ACS: A pooled analysis of GLASSY and TWILIGHT;International Journal of Cardiology;2023-07

5. Impact of Selection Preference on Longer-Term Outcomes between Bioresorbable Vascular Scaffold versus Everolimus-Eluting Stent for True Lumen Tracking-Recanalized Chronic Total Occlusion;International Heart Journal;2023-03-31